Nathan Kline Institute, Orangeburg, NY 10962, USA.
Exp Gerontol. 2012 May;47(5):347-52. doi: 10.1016/j.exger.2011.09.008. Epub 2011 Oct 1.
Neurofilament light (NFL) proteins in cerebrospinal fluid (CSF) are a marker of neuronal damage, especially subcortical axonal injury and white matter disease. Subjects with Alzheimer's disease (AD) have shown elevated levels of CSF NFL as compared to controls. However, the presence of the APOE ε4 allele, an established risk factor for AD, was not found to associate with higher CSF NFL concentrations. We examined whether TOMM40 variants, which have been reported to influence age of onset of AD and are in linkage disequilibrium with APOE, have an effect on CSF NFL levels, in 47 healthy, cognitively intact individuals with or without APOE ε4. Our results show that the presence of APOE ε4 alone does not affect CSF NFL levels significantly; however APOE and TOMM40 appear to interact. Subjects with APOE ε4 have higher CSF NFL levels than non-ε4 carriers, only when they do not carry a short poly-T variant of TOMM40, which is associated with later age of onset of AD, and may act as protective against the dose effect of ε4.
神经丝轻链(NFL)蛋白存在于脑脊液(CSF)中,是神经元损伤的标志物,尤其是皮质下轴突损伤和白质疾病。与对照组相比,阿尔茨海默病(AD)患者的 CSF NFL 水平升高。然而,APOE ε4 等位基因的存在,即 AD 的既定危险因素,与更高的 CSF NFL 浓度无关。我们研究了 TOMM40 变体是否有影响,因为已经有报道称 TOMM40 变体影响 AD 的发病年龄,并且与 APOE 连锁不平衡,在 47 名健康、认知正常的个体中,无论是否存在 APOE ε4,都对 CSF NFL 水平有影响。我们的结果表明,APOE ε4 的存在本身并不能显著影响 CSF NFL 水平;然而 APOE 和 TOMM40 似乎存在相互作用。只有当不携带与 AD 发病年龄较晚相关的短多态性 T 变体时,携带 APOE ε4 的个体的 CSF NFL 水平才高于非 ε4 携带者,而这种变体与 AD 发病年龄较晚相关,可能对 ε4 的剂量效应起保护作用。